Charles River Laboratories International, Inc. Financials

Market Capitalization $8.53 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	20.83
Forward PE	16.23
Price to Sales TTM	$2.10
Price to Book MRQ	$2.26
Enterprise to Revenue	2.74
Enterprise to EBITDA	11.73

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-30
Most Recent Quarter	2024-09-30
Profit Margin	10.44%
Operating Margin	14.69%
Return on Assets TTM	4.87%
Return on Equity TTM	11.92%

Income Statement

Revenue TTM	$4,060,915,968
Revenue per Share TTM	$78.97
Quarterly Revenue Growth	-1.60%
Gross Profit TTM	$1,459,020,032
EBITDA	$990,360,000
Net Income to Common TTM	$413,080,000
Diluted EPS TTM	$8.01
Quarterly Earnings Growth YoY	-20.30%

Balance Sheet

Total Cash MRQ	$210,171,008
Total Cash per Share MRQ	$4.11
Total Debt MRQ	$
Total Debt to Equity MRQ	72.18
Current Ratio MRQ	1.48
Book Value per Share MRQ	$73.97

Cash Flow

Operating Cash Flow TTM	$796,158,016
Levered Free Cash Flow TTM	$495,273,760

CRL Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	51,136,200
Float Shares	50,542,998
Avg 10 Volume	1,218,890
Avg 30 Volume	None
Shares Short	2,257,761
Short Ratio	4.17
Short % of Shares	5.73%
% Held by Insiders	0.92%
% Held by Institutions	103.47%

Stock Price Summary

Beta	1.38
Fifty Two Week Low	$160.85
Fifty Two Week High	$275.00
Fifty Two Week Change	-36.12%
Day 50 MA	$189.88
Day 200 MA	$205.54

Dividends and Splits

Forward Annual Dividend Rate	$1.20
Forward Annual Dividend Yield	0.73%
Trailing Annual Dividend Rate	$1.20
Trailing Annual Dividend Yield	0.73%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	1996-11-28
Last Split Factor
Last Split Date